BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 32603365)

  • 1. Genetic relationship between Hashimoto`s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto`s thyroiditis.
    Subhi O; Schulten HJ; Bagatian N; Al-Dayini R; Karim S; Bakhashab S; Alotibi R; Al-Ahmadi A; Ata M; Elaimi A; Al-Muhayawi S; Mansouri M; Al-Ghamdi K; Hamour OA; Jamal A; Al-Maghrabi J; Al-Qahtani MH
    PLoS One; 2020; 15(6):e0234566. PubMed ID: 32603365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics analysis identified shared differentially expressed genes as potential biomarkers for Hashimoto's thyroiditis-related papillary thyroid cancer.
    Liu C; Pan Y; Li Q; Zhang Y
    Int J Med Sci; 2021; 18(15):3478-3487. PubMed ID: 34522174
    [No Abstract]   [Full Text] [Related]  

  • 3. Genomic evidence of reactive oxygen species elevation in papillary thyroid carcinoma with Hashimoto thyroiditis.
    Yi JW; Park JY; Sung JY; Kwak SH; Yu J; Chang JH; Kim JH; Ha SY; Paik EK; Lee WS; Kim SJ; Lee KE; Kim JH
    Endocr J; 2015; 62(10):857-77. PubMed ID: 26211532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of
    Zhang Y; Xie X; Zhou H; Li B; Ding L; Cai Z; Song H; Zhao S; Xu H
    Front Endocrinol (Lausanne); 2023; 14():1131078. PubMed ID: 37455914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of lncRNA-mediated ceRNA regulatory networks and key genes associated with papillary thyroid cancer coexistent with Hashimoto's thyroiditis.
    Zhang Y; Tian Y
    BMC Endocr Disord; 2022 Oct; 22(1):252. PubMed ID: 36266640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-10 Restores MHC Class I Expression and Interferes With Immunity in Papillary Thyroid Cancer With Hashimoto Thyroiditis.
    Lu ZW; Hu JQ; Liu WL; Wen D; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
    Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32348468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying and analyzing the key genes shared by papillary thyroid carcinoma and Hashimoto's thyroiditis using bioinformatics methods.
    Liu TT; Yin DT; Wang N; Li N; Dong G; Peng MF
    Front Endocrinol (Lausanne); 2023; 14():1140094. PubMed ID: 37324256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Pathological Characteristics of Patients With Papillary Thyroid Carcinoma Coexisting With Hashimoto's Thyroiditis: A Retrospective Cohort Study.
    Yang Y; Liu J; Shi X; Wang M
    Cancer Control; 2023; 30():10732748231199647. PubMed ID: 37643366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent/recurrent disease in papillary thyroid carcinoma with/without Hashimoto's thyroiditis.
    Stanciu AE; Serdarevic N; Hurduc AE; Stanciu MM
    Scand J Clin Lab Invest; 2015 Nov; 75(7):539-48. PubMed ID: 26305420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological characterization and prognostic implication of FOXP3 and CK19 expression in papillary thyroid carcinoma and concomitant Hashimoto's thyroiditis.
    Mohamed SY; Ibrahim TR; Elbasateeny SS; Abdelaziz LA; Farouk S; Yassin MA; Embaby A
    Sci Rep; 2020 Jun; 10(1):10651. PubMed ID: 32606302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papillary Thyroid Carcinoma Emerging from Hashimoto Thyroiditis Demonstrates Increased PD-L1 Expression, Which Persists with Metastasis.
    Lubin D; Baraban E; Lisby A; Jalali-Farahani S; Zhang P; Livolsi V
    Endocr Pathol; 2018 Dec; 29(4):317-323. PubMed ID: 30121940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential protein expressions in papillary thyroid carcinoma patients with or without Hashimoto's thyroiditis].
    Lu HZ; Zhang N; Liu W; Zhu XY; Qi D; Wang Y; Liu XY; Li ZJ
    Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):463-468. PubMed ID: 32575941
    [No Abstract]   [Full Text] [Related]  

  • 13. Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer.
    Marotta V; Sciammarella C; Chiofalo MG; Gambardella C; Bellevicine C; Grasso M; Conzo G; Docimo G; Botti G; Losito S; Troncone G; De Palma M; Giacomelli L; Pezzullo L; Colao A; Faggiano A
    Endocr Relat Cancer; 2017 Sep; 24(9):485-493. PubMed ID: 28696209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between papillary thyroid carcinoma and histologically proven Hashimoto's thyroiditis: a meta-analysis.
    Lee JH; Kim Y; Choi JW; Kim YS
    Eur J Endocrinol; 2013 Mar; 168(3):343-9. PubMed ID: 23211578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid Carcinoma Coexisting with Hashimoto's Thyreoiditis: Clinicopathological and Molecular Characteristics Clue up Pathogenesis.
    Molnár C; Molnár S; Bedekovics J; Mokánszki A; Győry F; Nagy E; Méhes G
    Pathol Oncol Res; 2019 Jul; 25(3):1191-1197. PubMed ID: 30666518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients.
    Liang J; Zeng W; Fang F; Yu T; Zhao Y; Fan X; Guo N; Gao X
    Acta Otorhinolaryngol Ital; 2017 Oct; 37(5):393-400. PubMed ID: 29165434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis.
    Han LT; Hu JQ; Ma B; Wen D; Zhang TT; Lu ZW; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
    Diagn Pathol; 2019 Jun; 14(1):52. PubMed ID: 31159823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma.
    Zhang Y; Dai J; Wu T; Yang N; Yin Z
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):1021-6. PubMed ID: 24619663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and pathological differences between papillary thyroid carcinoma with Graves' disease and papillary thyroid carcinoma with Hashimoto's thyroiditis].
    Xu DD; Lun Y; Liu X; Jiang H; Song JB; Duan ZQ; Xin SJ; Zhang J
    Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(32):2491-2495. PubMed ID: 28835054
    [No Abstract]   [Full Text] [Related]  

  • 20. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
    Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.